The Latest Breaking News from Altria

Altria stock rebounded on Thursday, after sliding Wednesday, as the FDA ordered Juul to stop selling its products in the U.S.

The stock markets pulled back yesterday after the Fed rate hike amid recessionary concerns. Considering the volatile market backdrop, investing in dividend-paying blue-chip stocks AT&T (T), LyondellBasell Industries N.V. (LYB), The Bank of Nova Scotia (BNS), International Business Machines Corp. (IBM), and Altria Group (MO) could be wise.

Altria Group Inc (NYSE:MO) reported a first-quarter FY22 sales decline of 2.4% year-on-year to $5.89 billion. Revenues net of excise taxes fell 1.3% to $4.82 billion. Net revenues for smokeable products increased 0.3%, and oral tobacco products fell 2.1%. Total cigarette volume declined 12%, with Marlboro shipment volume down 11.1%. Marlboro retail share…

Lingering supply crunch and soaring inflation have increased the odds of the Fed raising interest rates aggressively later this year, which could dampen corporate earnings. Moreover, as the GDP is estimated to be lower than the prior estimate, many analysts expect the economy to witness recessionary pressure. Therefore, it could…

Altria says an administrative law judge dismissed a federal lawsuit alleging that its investment into vaping company Juul violates anticompetitive laws

Altria Group Inc (NYSE:MO) reported fourth-quarter FY21 revenues net of excise taxes of $5.09 billion, +0.6% year-on-year, beating the analyst consensus of $5 billion. Net revenues declined 0.8% to $6.26 billion. Revenue for smokeable products increased 2.3%, and oral tobacco products rose 4.8%. Gross profit climbed 5.4% Y/Y to $3.3 billion. The operating…